| Trial ID: | L4759 |
| Source ID: | NCT00123643
|
| Associated Drug: |
Rosiglitazone
|
| Title: |
Vascular Effects of Rosiglitazone Versus Glyburide in Type 2 Diabetic Patients
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
YES
|
| Results: |
https://ClinicalTrials.gov/show/NCT00123643/results
|
| Conditions: |
Type 2 Diabetes Mellitus
|
| Interventions: |
DRUG: rosiglitazone|DRUG: glyburide
|
| Outcome Measures: |
Primary: Flow Mediated Dilation, Measure of endothelial function, change from baseline to 6 months |
|
| Sponsor/Collaborators: |
Sponsor: St. Paul Heart Clinic | Collaborators: GlaxoSmithKline
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
36
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION
|
| Start Date: |
2003-05
|
| Completion Date: |
2005-12
|
| Results First Posted: |
2012-08-09
|
| Last Update Posted: |
2013-07-15
|
| Locations: |
St. Paul Heart Clinic, St. Paul, Minnesota, 55102, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT00123643
|
